Barclays raised the firm’s price target on Bausch + Lomb (BLCO) to $20 from $17 and keeps an Equal Weight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Maintaining Sell: Structural Overhangs and Margin Shortfalls Overshadow Bausch + Lomb’s Growth Story
- Bausch + Lomb Signals Profitable Growth After Record Year
- Bausch + Lomb Lifts 2025 Revenue on Dry Eye and Vision Care Growth
- Bausch + Lomb sees FY26 revenue $5.375B-$5.475B, consensus $5.38B
- Bausch + Lomb reports Q4 non-GAAP EPS 32c, consensus 36c